More Ways to Connect
  LinkedIn Twitter YouTube Instagram
  RSS
Search
Events

 


Medical Grand Rounds: “Current Controversies in Clinical Medicine – Anti-angiogenics in metastatic breast cancer”
Date: Wednesday, March 16, 2011
Time: Noon - 1 p.m.
Location: Medical Sciences Building Room 7051

Description:

The Department of Internal Medicine is sponsoring a special themed medical grand rounds,  "Current Controversies in Clinical Medicine – Anti-angiogenics in metastatic breast cancer.”

At this "Current Controversies in Clinical Medicine” event, audience members will have the opportunity to participate in a lively and interactive discussion about a controversy that has been raging in the media during the past two months relating to the use of bevacizumab (Avastin) in metastatic breast cancer.

Featured speakers:
  • Olivier Rixe, PhD, MD, professor of clinical medicine, division of hematology-oncology, will discuss the principles behind anti-angiogenic therapies and their activities in several different types of cancer.
  • Mahmoud Charif, MD, assistant professor of clinical medicine, division of hematology-oncology, will then discuss the data that led to the approval and the later disapproval of bevacizumab by the FDA.
  • George Atweh, MD, Director of the Division of Hematology-Oncology and UC Cancer Institute, will talk about other targeted therapies that have had a dramatic impact on the outcome of patients with other types of cancer.
  • Frank Putnam, MD, professor of pediatrics and psychiatry and Director of the Mayerson Center for Safe & Healthy Children at Cincinnati Children's Hospital Medical Center, will lead a general discussion of the ethics, economics and the choices we have to make as a society when we use extremely expensive new drugs that result in a modest improvement in survival of patients with cancer.

For more information:

Contact Mary Rich at (513) 245-3425 or mary.rich@uc.edu



< MARCH 2011 >
S M T W T F S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

VIEW BY SUBJECT


 back to list | back to top